Global Pressure Ulcer Treatment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Global Pressure Ulcer Treatment Market Segmentation, By Treatment (Wound Care Dressings, Wound Care Devices, Active Therapies, and Others), Diagnosis (Blood Tests and Others), Ulcer Type (Stage-1, Stage-2, Stage-3, Stage-4, and Deep Tissue Injury), End-Users (Clinic, Hospital, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Industry Trends and Forecast to 2032

Pressure Ulcer Treatment Market Size

• The global pressure ulcer treatment market size was valued at USD 9.65 billion in 2024 and is expected to reach USD 15.73 billion by 2032, at a CAGR of 6.30% during the forecast period
• The market growth is largely fueled by the increasing prevalence of pressure ulcers (bedsores) across aging and immobile patient populations, particularly in long-term care facilities, hospitals, and home healthcare settings. This growing burden is driving demand for advanced wound care solutions
• Furthermore, rising awareness about early-stage ulcer management, alongside healthcare regulations mandating pressure injury prevention protocols, is establishing pressure ulcer treatment as a critical component of chronic wound care. These converging factors are accelerating the uptake of pressure ulcer treatment solutions, thereby significantly boosting the industry's growth

Pressure Ulcer Treatment Market Analysis

• Pressure ulcer treatment solutions, aimed at managing and healing injuries to the skin and underlying tissue due to prolonged pressure, have become increasingly vital in both acute and long-term care settings. These treatments include advanced wound dressings, negative pressure wound therapy (NPWT), and support surfaces, significantly improving outcomes for at-risk patient populations such as the elderly and immobile
• The rising prevalence of chronic conditions, aging populations, and increased hospital admissions are major factors driving demand for pressure ulcer treatments globally. Healthcare providers are prioritizing early prevention and wound care protocols, further fueling market growth
• North America dominated the pressure ulcer treatment market with the largest revenue share of 40.05% in 2024, attributed to well-established healthcare infrastructure, high awareness among healthcare professionals, and wide adoption of advanced wound care technologies. The U.S. continues to lead the region, bolstered by favorable reimbursement policies, robust investments in wound care research, and increasing geriatric populations
• Asia-Pacific is projected to be the fastest-growing region in the pressure ulcer treatment market during the forecast period (2025–2032), driven by rapid improvements in healthcare infrastructure, increasing awareness about chronic wound management, and the growing elderly population in countries such as Japan, China, and India
• The wound care dressings segment dominated the pressure ulcer treatment market with the largest revenue share of 42.6% in 2024, driven by the cost-effectiveness and widespread clinical adoption of foam, hydrogel, and hydrocolloid dressings

Report Scope and Pressure Ulcer Treatment Market Segmentation  

Pressure Ulcer Treatment Market Trends

“Improved Wound Care Protocols and Technology Integration”

• A significant and accelerating trend in the global pressure ulcer treatment market is the growing adoption of advanced wound care therapies and multimodal treatment protocols, which enhance healing outcomes and reduce hospitalization durations for patients with pressure injuries

  • For instance, hydrocolloid, alginate, and foam dressings are now widely used in clinical settings due to their ability to maintain a moist environment and promote autolytic debridement. Similarly, negative pressure wound therapy (NPWT) devices are increasingly utilized for stage 3 and stage 4 ulcers to accelerate granulation and tissue regeneration

• The integration of electromagnetic stimulation, electrical stimulation therapy, and hyperbaric oxygen therapy into chronic wound care plans is contributing to better management of deep tissue injuries and non-healing ulcers. These innovations allow healthcare professionals to individualize treatment plans based on wound stage and patient comorbidities
• Furthermore, the expanding use of portable wound care devices and smart dressings embedded with sensors (for moisture level and pH monitoring) offers continuous feedback and supports timely interventions
• Hospitals and wound care centers are also adopting pressure-relieving mattresses, specialized cushions, and repositioning protocols to reduce the incidence of pressure ulcers in immobile patients, particularly in long-term care and ICU settings
• As awareness increases around cost-effective and patient-centered care for chronic wounds, demand for comprehensive pressure ulcer treatment solutions is growing across acute care, homecare, and outpatient wound clinics worldwide

Pressure Ulcer Treatment Market Dynamics

Driver

“Growing Need Due to Rising Incidence of Chronic Conditions and Aging Population”

• The increasing prevalence of chronic illnesses such as diabetes and cardiovascular diseases, combined with an aging population susceptible to limited mobility, is a major factor driving the demand for pressure ulcer treatment solutions

  • For instance, according to the World Health Organization, the global population aged 60 years and older is expected to reach 2.1 billion by 2050, substantially increasing the at-risk population for pressure ulcers

• As healthcare providers become more focused on preventive wound care and long-term patient management, demand for advanced dressings, wound care devices, and active therapies is expected to grow
• Furthermore, growing awareness about pressure ulcer prevention protocols in hospitals, long-term care facilities, and home care settings is accelerating market adoption of effective wound care technologies
• The rising preference for personalized wound care, telehealth-based wound monitoring, and the availability of innovative treatment solutions are key trends fostering market expansion

Restraint/Challenge

“High Treatment Costs and Limited Reimbursement Coverage”

• The cost of advanced pressure ulcer treatment, including specialty wound care devices, biologic dressings, and surgical interventions, remains high and often not fully covered by insurance, posing a significant financial burden to patients and healthcare systems

  • For instance, in many developing countries, reimbursement policies either partially support or exclude modern wound care technologies, limiting their accessibility in public healthcare setups

• Inadequate training of healthcare professionals in pressure ulcer management and the lack of standardized treatment guidelines also hinder effective diagnosis and therapy, especially in resource-limited settings
• In addition, the high cost of long-term hospitalization for severe pressure ulcers (Stage 3 or 4) and surgical wound closure procedures further escalates healthcare expenses
• Overcoming these challenges requires broader policy reforms to expand reimbursement schemes, increase training initiatives in wound care management, and promote the development of cost-effective treatment options suitable for widespread adoption

Pressure Ulcer Treatment Market Scope

The market is segmented on the basis of treatment, diagnosis, ulcer type, end-users, and distribution channel.

• By Treatment

On the basis of treatment, the pressure ulcer treatment market is segmented into wound care dressings, wound care devices, active therapies, and others. The wound care dressings segment dominated the market with the largest revenue share of 42.6% in 2024, driven by the cost-effectiveness and widespread clinical adoption of foam, hydrogel, and hydrocolloid dressings.

The active therapies segment is projected to grow at the fastest CAGR of 9.8% from 2025 to 2032, attributed to the increasing use of NPWT (negative pressure wound therapy), oxygen therapy, and electrical stimulation in advanced and chronic wound management.

• By Diagnosis

On the basis of diagnosis, the pressure ulcer treatment market is segmented into blood tests and others. The others segment accounted for the largest share of 76.3% in 2024, including physical examination, wound staging, and imaging-based evaluation methods widely used across healthcare settings.

The blood tests segment is expected to register fastest CAGR of 7.1% during the forecast period, owing to increased reliance on lab-based inflammation markers and infection monitoring in moderate-to-severe pressure ulcer patients.

• By Ulcer Type

On the basis of ulcer type, the pressure ulcer treatment market is segmented into stage-1, stage-2, stage-3, stage-4, and deep tissue injury. The stage-2 segment held the largest revenue share of 33.8% in 2024, as this stage is highly responsive to conventional treatment, and early detection at this stage helps reduce hospital burden.

The Stage-4 segment is expected to grow at the fastest CAGR of 10.2% from 2025 to 2032, driven by increasing incidence in elderly populations and critically ill patients requiring long-term care.

• By End Users

On the basis of end users, the pressure ulcer treatment market is segmented into clinic, hospital, and others. The Hospital segment dominated the market with a share of 58.7% in 2024 due to the high volume of inpatient cases and availability of advanced wound care services.

The clinic segment is projected to grow at a CAGR of 8.9% during the forecast period, driven by the expansion of outpatient wound care centers and rising patient preference for non-hospital-based treatments.

• By Distribution Channel

on the basis of distribution channel, the pressure ulcer treatment market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment accounted for the highest share of 46.2% in 2024, owing to direct procurement for inpatient treatment and integration with hospital formularies.

The online pharmacy segment is forecasted to grow at the fastest CAGR of 11.5% from 2025 to 2032, due to growing homecare usage, increased internet penetration, and rising consumer inclination towards convenient access to wound care products.

Pressure Ulcer Treatment Market Regional Analysis

• North America pressure ulcer treatment market dominated globally with the largest revenue share of 40.05% in 2024, driven by rising prevalence of chronic conditions
• Increasing awareness regarding pressure injuries, and strong access to advanced wound care products
• The market is projected to grow at a CAGR of 7.1% from 2025 to 2032, due to favorable reimbursement frameworks and the presence of major industry players

U.S. Pressure Ulcer Treatment Market Insight

The U.S. pressure ulcer treatment market accounted for 81.05% of North America’s share in 2024. It is expected to expand at a CAGR of 6.9% during the forecast period, supported by high healthcare expenditure, early technology adoption, and stringent CMS guidelines on hospital-acquired pressure ulcers

Europe Pressure Ulcer Treatment Market Insight

The Europe pressure ulcer treatment market represented 28.4% of the global market share in 2024, owing to the region’s aging population, expanding clinical research, and national healthcare initiatives targeting chronic wound care. The market is set to grow at a CAGR of 7.6% from 2025 to 2032, driven by favorable public healthcare access and the growing demand for advanced wound management

U.K. Pressure Ulcer Treatment Market Insight

The U.K. pressure ulcer treatment market captured 21.7% of Europe’s market share in 2024, fueled by NHS investments in wound prevention and early intervention programs. It is projected to grow at a CAGR of 7.9%, driven by rising patient awareness, integration of telehealth wound care, and a strong focus on reducing hospital-acquired injuries

Germany Pressure Ulcer Treatment Market Insight

The Germany Pressure Ulcer Treatment Market held 19.3% of Europe’s market share in 2024, and is expected to grow at the fastest CAGR in the region at 8.4%. Growth is driven by adoption of digital wound diagnostics, advanced wound care dressings, and a robust healthcare R&D ecosystem

Asia-Pacific Pressure Ulcer Treatment Market Insight

The Asia-Pacific pressure ulcer treatment market held 19.5% of the global market in 2024, with significant contributions from emerging economies. The region is forecasted to expand at the highest CAGR of 9.6% from 2025 to 2032, due to increasing geriatric population, healthcare infrastructure upgrades, and local manufacturing of affordable wound care products

Japan Pressure Ulcer Treatment Market Insight

The Japan pressure ulcer treatment market accounted for 26.4% of the Asia-Pacific share in 2024, supported by advanced aging care models and digitized hospital systems. It is anticipated to grow at a CAGR of 9.1%, with rising emphasis on home care and the integration of smart wound care solutions

China Pressure Ulcer Treatment Market Insight

The China pressure ulcer treatment market held the largest regional share in Asia-Pacific at 38.2% in 2024, driven by strong domestic production and urban healthcare expansion. The market is expected to grow at a CAGR of 9.9%, supported by public awareness programs, smart city healthcare initiatives, and increasing investments in elder care infrastructure

Pressure Ulcer Treatment Market Share

The pressure ulcer treatment industry is primarily led by well-established companies, including:

• Smith+Nephew (U.K.)
• Integra LifeSciences (U.S.)
• Baxter (U.S.)
• Mölnlycke Health Care AB (Sweden)
• Cardinal Health (U.S.)
• Essity Aktiebolag (Sweden)
• 3M (U.S.)
• B. Braun SE (Germany)
• Coloplast A/S (Denmark)
• Convatec Group PLC (U.K.)
• Tissue Regenix (U.K.)
• Stryker (U.S.)
• Stiegelmeyer GmbH & Co. KG (Germany)
• Invacare Corporation (U.S.)
• GF Health Products, Inc. (U.S.)
• Essity Health & Medical (Germany)
• Arjo (Sweden)

Latest Developments in Global Pressure Ulcer Treatment Market

• In March 2025, Open Wound Research and Venture Medical, LLC entered into a collaborative research agreement aimed at advancing pressure ulcer treatment. As part of this collaboration, Venture Medical obtained comprehensive pressure ulcer data from Open Wound Research to assess the effectiveness of CAMPS compared to standard of care (SOC) treatments
• In June 2022, Michelin unveiled the MICHELIN AirProne at the Intensive Care Show 2022, a groundbreaking air cushion system designed for patients with acute respiratory distress syndrome (ARDS). This innovative product aims to improve patient care by promoting optimal positioning and comfort for ARDS patients. The MICHELIN AirProne is designed to enhance ventilation and reduce the risk of complications, offering a novel solution for intensive care settings
• In January 2021, Smith & Nephew Plc acquired Osiris Therapeutics, a company specializing in regenerative medicine and the production of skin and bone substitutes. This acquisition strengthens Smith & Nephew's portfolio in advanced wound care and regenerative therapies. By integrating Osiris Therapeutics’ innovative technologies, Smith & Nephew aims to expand its capabilities in offering cutting-edge solutions for wound healing and tissue regeneration

SKU-66579